Filing Details

Accession Number:
0000899243-19-019423
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-10 16:05:44
Reporting Period:
2019-07-08
Accepted Time:
2019-07-10 16:05:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610664 Cesare Orlandi C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-08 6,672 $21.10 75,155 No 4 M Direct
Common Stock Acquisiton 2019-07-08 13,346 $21.10 88,501 No 4 M Direct
Common Stock Acquisiton 2019-07-08 6,672 $21.10 95,173 No 4 M Direct
Common Stock Acquisiton 2019-07-08 8,896 $21.10 104,069 No 4 M Direct
Common Stock Disposition 2019-07-08 28,002 $28.33 76,067 No 4 S Direct
Common Stock Disposition 2019-07-08 7,584 $27.60 68,483 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-07-08 6,672 $0.00 6,672 $21.10
Common Stock Stock Option (right to buy) Disposition 2019-07-08 13,346 $0.00 13,346 $21.10
Common Stock Stock Option (right to buy) Disposition 2019-07-08 6,672 $0.00 6,672 $21.10
Common Stock Stock Option (right to buy) Disposition 2019-07-08 8,896 $0.00 8,896 $18.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-06-25 2023-03-04 No 4 M Direct
0 2023-03-04 No 4 M Direct
0 2023-03-04 No 4 M Direct
0 2023-08-05 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2019.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.45, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.06 to $27.99, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  4. These options vested in four equal installments on March 4, 2014, 2015, 2016 and 2017.
  5. Options to purchase 13,345 shares of Common Stock were granted to the reporting person on March 4, 2013, which options were subject to vesting in up to four equal annual installments based upon the level of LNTH's satisfaction of certain performance criteria for each of fiscal years 2013, 2014, 2015 and 2016. A certain level of the performance criteria were satisfied for each of fiscal years 2013 and 2014, resulting in the partial vesting as to 6,672 shares of Common Stock.
  6. These options vested in four equal installments on August 5, 2014, 2015, 2016 and 2017.